Prognostic Role of Non-Identification of Sentinel Lymph Node in Cutaneous Melanoma Patients: An Observational Retrospective Study

• Main Authors: Ruggero Moro, Cintia Arjona-Aguilera, Celia Requena, Virginia Pont-Sanjuan, Victor Traves, Esperanza Manrique-Silva, Eduardo Nagore
• Format: Article
• Language: English
• Published: MDPI AG 2020-10-01
• Series: Cancers
• Subjects: melanoma; lymph node biopsy; sentinel; identification
• Online Access: https://www.mdpi.com/2072-6694/12/11/3151

<i>Background</i>: Sentinel lymph node (SLN) status is recognized as the most important prognostic factor for patients with cutaneous melanoma. However, sometimes it is not possible to identify SLN. The phenomenon of non-identification of SLN and its prognostic role have not been thoroughly evaluated in melanoma literature. The objective of this study was to identify which patient or tumor variables may be associated to non-identification of SLN and to evaluate the prognostic role of non-identification of SLN. <i>Methods</i>: Observational retrospective study of 834 cutaneous melanoma patients who underwent SLN biopsy at Instituto Valenciano de Oncología. <i>Results</i>: Forty-two patients (5%) presented non-identification of SLN. Patients with age at diagnosis of ≥ 64 years, obesity (BMI ≥ 30), and head and neck localization were at higher risk of non-identification of SLN. Non-identified SLN patients had worse nodal disease-free survival with respect to negative SLN patients, but not worse melanoma-specific survival. <i>Conclusions</i>: Our findings suggest a need to follow-up patients with non-identified SLN in the same way as patients with positive SLN.